Severe vagal response after endotoxin administration in humans
Endotoxin administration to humans is a common means to study systemic inflammation. Worldwide, thousands of volunteers have received endotoxin, and adverse events are rarely reported. The aim of this report was to increase awareness of specific risks of the intravenous administration of endotoxin t...
Gespeichert in:
Veröffentlicht in: | Intensive care medicine 2004-12, Vol.30 (12), p.2279-2281 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2281 |
---|---|
container_issue | 12 |
container_start_page | 2279 |
container_title | Intensive care medicine |
container_volume | 30 |
creator | VAN EIJK, Lucas T. G. J PICKKERS, Peter SMITS, Paul BOUW, Martijn P. W. J. M VAN DER HOEVEN, Johannes G |
description | Endotoxin administration to humans is a common means to study systemic inflammation. Worldwide, thousands of volunteers have received endotoxin, and adverse events are rarely reported. The aim of this report was to increase awareness of specific risks of the intravenous administration of endotoxin to human volunteers.
Report of four cases who developed severe bradycardia or protracted asystole after administration of endotoxin. Interviews with investigators at three large centers that conduct normal volunteer endotoxin studies.
Clinical research unit.
Four subjects developed severe bradycardia or protracted asystole, approximately 1 h after administration of endotoxin. Further analyses revealed that the subjects had a history of vasovagal syncope or a positive head-tilt test, indicating increased vagal sensitivity. Relative volume depletion associated with fasting overnight may have predisposed these subjects to this condition.
These responses are very rare and are likely due to the cardioinhibitory Bezold-Jarisch reflex. A thorough screening regarding a history of vagal sensitivity and liberal oral or intravenous fluid administration prior to and during the endotoxin challenge may decrease the risk of these events. |
doi_str_mv | 10.1007/s00134-004-2477-0 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_216201090</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>781371741</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-e718708813b251a4756576f54a6f201dc323bbb4ccadc6944657f5022687f1003</originalsourceid><addsrcrecordid>eNpFkE1LAzEQhoMotlZ_gBdZBI_RTD63F0GKX1DwoJ5DNpvolm62JrtF_71ZWuhpYOaZd5gHoUsgt0CIukuEAOOYEI4pVwqTIzQFzigGyspjNCWMU8wlpxN0ltIq00oKOEUTEAIUSDJF9-9u66IrtubLrIvo0qYLyRXG9y4WLtRd3_02oTB124Qm9dH0TReK3PkeWhPSOTrxZp3cxb7O0OfT48fiBS_fnl8XD0tsmZA9dgpKRcoSWEUFGK6EFEp6wY30lEBtGWVVVXFrTW3lnPM89oJQKkvl86tshq53uZvY_Qwu9XrVDTHkk5qCzBFkPkKwg2zsUorO601sWhP_NBA9CtM7YToL06MwPe5c7YOHqnX1YWNvKAM3e8Aka9Y-mmCbdOAkg5JKYP8P93Ej</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>216201090</pqid></control><display><type>article</type><title>Severe vagal response after endotoxin administration in humans</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>VAN EIJK, Lucas T. G. J ; PICKKERS, Peter ; SMITS, Paul ; BOUW, Martijn P. W. J. M ; VAN DER HOEVEN, Johannes G</creator><creatorcontrib>VAN EIJK, Lucas T. G. J ; PICKKERS, Peter ; SMITS, Paul ; BOUW, Martijn P. W. J. M ; VAN DER HOEVEN, Johannes G</creatorcontrib><description>Endotoxin administration to humans is a common means to study systemic inflammation. Worldwide, thousands of volunteers have received endotoxin, and adverse events are rarely reported. The aim of this report was to increase awareness of specific risks of the intravenous administration of endotoxin to human volunteers.
Report of four cases who developed severe bradycardia or protracted asystole after administration of endotoxin. Interviews with investigators at three large centers that conduct normal volunteer endotoxin studies.
Clinical research unit.
Four subjects developed severe bradycardia or protracted asystole, approximately 1 h after administration of endotoxin. Further analyses revealed that the subjects had a history of vasovagal syncope or a positive head-tilt test, indicating increased vagal sensitivity. Relative volume depletion associated with fasting overnight may have predisposed these subjects to this condition.
These responses are very rare and are likely due to the cardioinhibitory Bezold-Jarisch reflex. A thorough screening regarding a history of vagal sensitivity and liberal oral or intravenous fluid administration prior to and during the endotoxin challenge may decrease the risk of these events.</description><identifier>ISSN: 0342-4642</identifier><identifier>EISSN: 1432-1238</identifier><identifier>DOI: 10.1007/s00134-004-2477-0</identifier><identifier>PMID: 15517160</identifier><identifier>CODEN: ICMED9</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Adult ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Blood coagulation. Blood cells ; Bradycardia - chemically induced ; Endotoxins - adverse effects ; Female ; Fundamental and applied biological sciences. Psychology ; General aspects, investigation methods, hemostasis, fibrinolysis ; Heart Arrest - chemically induced ; Human Experimentation ; Humans ; Intensive care medicine ; Male ; Medical sciences ; Molecular and cellular biology ; Platelet</subject><ispartof>Intensive care medicine, 2004-12, Vol.30 (12), p.2279-2281</ispartof><rights>2005 INIST-CNRS</rights><rights>Copyright Springer-Verlag 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-e718708813b251a4756576f54a6f201dc323bbb4ccadc6944657f5022687f1003</citedby><cites>FETCH-LOGICAL-c356t-e718708813b251a4756576f54a6f201dc323bbb4ccadc6944657f5022687f1003</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16318261$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15517160$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>VAN EIJK, Lucas T. G. J</creatorcontrib><creatorcontrib>PICKKERS, Peter</creatorcontrib><creatorcontrib>SMITS, Paul</creatorcontrib><creatorcontrib>BOUW, Martijn P. W. J. M</creatorcontrib><creatorcontrib>VAN DER HOEVEN, Johannes G</creatorcontrib><title>Severe vagal response after endotoxin administration in humans</title><title>Intensive care medicine</title><addtitle>Intensive Care Med</addtitle><description>Endotoxin administration to humans is a common means to study systemic inflammation. Worldwide, thousands of volunteers have received endotoxin, and adverse events are rarely reported. The aim of this report was to increase awareness of specific risks of the intravenous administration of endotoxin to human volunteers.
Report of four cases who developed severe bradycardia or protracted asystole after administration of endotoxin. Interviews with investigators at three large centers that conduct normal volunteer endotoxin studies.
Clinical research unit.
Four subjects developed severe bradycardia or protracted asystole, approximately 1 h after administration of endotoxin. Further analyses revealed that the subjects had a history of vasovagal syncope or a positive head-tilt test, indicating increased vagal sensitivity. Relative volume depletion associated with fasting overnight may have predisposed these subjects to this condition.
These responses are very rare and are likely due to the cardioinhibitory Bezold-Jarisch reflex. A thorough screening regarding a history of vagal sensitivity and liberal oral or intravenous fluid administration prior to and during the endotoxin challenge may decrease the risk of these events.</description><subject>Adult</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Blood coagulation. Blood cells</subject><subject>Bradycardia - chemically induced</subject><subject>Endotoxins - adverse effects</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>General aspects, investigation methods, hemostasis, fibrinolysis</subject><subject>Heart Arrest - chemically induced</subject><subject>Human Experimentation</subject><subject>Humans</subject><subject>Intensive care medicine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Molecular and cellular biology</subject><subject>Platelet</subject><issn>0342-4642</issn><issn>1432-1238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpFkE1LAzEQhoMotlZ_gBdZBI_RTD63F0GKX1DwoJ5DNpvolm62JrtF_71ZWuhpYOaZd5gHoUsgt0CIukuEAOOYEI4pVwqTIzQFzigGyspjNCWMU8wlpxN0ltIq00oKOEUTEAIUSDJF9-9u66IrtubLrIvo0qYLyRXG9y4WLtRd3_02oTB124Qm9dH0TReK3PkeWhPSOTrxZp3cxb7O0OfT48fiBS_fnl8XD0tsmZA9dgpKRcoSWEUFGK6EFEp6wY30lEBtGWVVVXFrTW3lnPM89oJQKkvl86tshq53uZvY_Qwu9XrVDTHkk5qCzBFkPkKwg2zsUorO601sWhP_NBA9CtM7YToL06MwPe5c7YOHqnX1YWNvKAM3e8Aka9Y-mmCbdOAkg5JKYP8P93Ej</recordid><startdate>20041201</startdate><enddate>20041201</enddate><creator>VAN EIJK, Lucas T. G. J</creator><creator>PICKKERS, Peter</creator><creator>SMITS, Paul</creator><creator>BOUW, Martijn P. W. J. M</creator><creator>VAN DER HOEVEN, Johannes G</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20041201</creationdate><title>Severe vagal response after endotoxin administration in humans</title><author>VAN EIJK, Lucas T. G. J ; PICKKERS, Peter ; SMITS, Paul ; BOUW, Martijn P. W. J. M ; VAN DER HOEVEN, Johannes G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-e718708813b251a4756576f54a6f201dc323bbb4ccadc6944657f5022687f1003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Blood coagulation. Blood cells</topic><topic>Bradycardia - chemically induced</topic><topic>Endotoxins - adverse effects</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>General aspects, investigation methods, hemostasis, fibrinolysis</topic><topic>Heart Arrest - chemically induced</topic><topic>Human Experimentation</topic><topic>Humans</topic><topic>Intensive care medicine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Molecular and cellular biology</topic><topic>Platelet</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>VAN EIJK, Lucas T. G. J</creatorcontrib><creatorcontrib>PICKKERS, Peter</creatorcontrib><creatorcontrib>SMITS, Paul</creatorcontrib><creatorcontrib>BOUW, Martijn P. W. J. M</creatorcontrib><creatorcontrib>VAN DER HOEVEN, Johannes G</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Intensive care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>VAN EIJK, Lucas T. G. J</au><au>PICKKERS, Peter</au><au>SMITS, Paul</au><au>BOUW, Martijn P. W. J. M</au><au>VAN DER HOEVEN, Johannes G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Severe vagal response after endotoxin administration in humans</atitle><jtitle>Intensive care medicine</jtitle><addtitle>Intensive Care Med</addtitle><date>2004-12-01</date><risdate>2004</risdate><volume>30</volume><issue>12</issue><spage>2279</spage><epage>2281</epage><pages>2279-2281</pages><issn>0342-4642</issn><eissn>1432-1238</eissn><coden>ICMED9</coden><abstract>Endotoxin administration to humans is a common means to study systemic inflammation. Worldwide, thousands of volunteers have received endotoxin, and adverse events are rarely reported. The aim of this report was to increase awareness of specific risks of the intravenous administration of endotoxin to human volunteers.
Report of four cases who developed severe bradycardia or protracted asystole after administration of endotoxin. Interviews with investigators at three large centers that conduct normal volunteer endotoxin studies.
Clinical research unit.
Four subjects developed severe bradycardia or protracted asystole, approximately 1 h after administration of endotoxin. Further analyses revealed that the subjects had a history of vasovagal syncope or a positive head-tilt test, indicating increased vagal sensitivity. Relative volume depletion associated with fasting overnight may have predisposed these subjects to this condition.
These responses are very rare and are likely due to the cardioinhibitory Bezold-Jarisch reflex. A thorough screening regarding a history of vagal sensitivity and liberal oral or intravenous fluid administration prior to and during the endotoxin challenge may decrease the risk of these events.</abstract><cop>Heidelberg</cop><cop>Berlin</cop><pub>Springer</pub><pmid>15517160</pmid><doi>10.1007/s00134-004-2477-0</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0342-4642 |
ispartof | Intensive care medicine, 2004-12, Vol.30 (12), p.2279-2281 |
issn | 0342-4642 1432-1238 |
language | eng |
recordid | cdi_proquest_journals_216201090 |
source | MEDLINE; Springer Nature - Complete Springer Journals |
subjects | Adult Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Blood coagulation. Blood cells Bradycardia - chemically induced Endotoxins - adverse effects Female Fundamental and applied biological sciences. Psychology General aspects, investigation methods, hemostasis, fibrinolysis Heart Arrest - chemically induced Human Experimentation Humans Intensive care medicine Male Medical sciences Molecular and cellular biology Platelet |
title | Severe vagal response after endotoxin administration in humans |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T11%3A51%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Severe%20vagal%20response%20after%20endotoxin%20administration%20in%20humans&rft.jtitle=Intensive%20care%20medicine&rft.au=VAN%20EIJK,%20Lucas%20T.%20G.%20J&rft.date=2004-12-01&rft.volume=30&rft.issue=12&rft.spage=2279&rft.epage=2281&rft.pages=2279-2281&rft.issn=0342-4642&rft.eissn=1432-1238&rft.coden=ICMED9&rft_id=info:doi/10.1007/s00134-004-2477-0&rft_dat=%3Cproquest_cross%3E781371741%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=216201090&rft_id=info:pmid/15517160&rfr_iscdi=true |